Related Experiment Videos
Ionic mechanism of electrical alternans.
Jeffrey J Fox1, Jennifer L McHarg, Robert F Gilmour
1Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853-6401, USA.
American Journal of Physiology. Heart and Circulatory Physiology
|January 15, 2002
Summary
New cardiac models recreate action potential duration (APD) alternans in canine ventricles. This ionic model development provides a basis for understanding and treating alternans, crucial for cardiac electrophysiology research.
Area of Science:
- Cardiac Electrophysiology
- Computational Biology
- Pharmacology
Background:
- Action potential duration (APD) alternans is a key feature of rapid pacing in canine ventricles.
- Existing ionic models of cardiac myocytes fail to reproduce APD alternans.
- Understanding the ionic basis of APD alternans is critical for developing therapeutic strategies.
Purpose of the Study:
- To develop a novel ionic model capable of simulating APD alternans in the canine ventricle.
- To identify specific ionic current modifications responsible for APD alternans.
- To establish an ionic basis for APD alternans to guide pharmacological interventions.
Main Methods:
- Formulation of a new ionic model incorporating updated experimental data and previous model parameters.
- Modification of key ionic currents: inward rectifier K+ (I(K1)), rapid (I(Kr)) and slow (I(Ks)) delayed rectifier K+, and L-type Ca2+ (I(Ca)).
- Inclusion of simplified intracellular calcium dynamics.
Main Results:
- The developed model successfully reproduced APD alternans at cycle lengths of 150-210 ms.
- APD alternans amplitude reached a maximum of 39 ms.
- APD alternans was suppressed by reducing I(Ca) or enhancing I(K1), I(Kr), or I(Ks).
Conclusions:
- The study establishes a robust ionic basis for APD alternans in canine ventricular models.
- The findings provide a foundation for developing targeted pharmacological treatments to eliminate alternans.
- This model serves as a valuable tool for future research in cardiac electrophysiology and drug development.